07.01.2016 • News

Den Hartogh to Acquire InterBulk

Family owned Dutch logistics company Den Hartogh is to acquire the UK’s Interbulk, creating the world’s third largest provider of logistic services to the chemical industry.

The boards of both companies have agreed the transaction which sees Den Hartogh paying 9 pence for each InterBulk share, valuing the company (excluding net debt) at around £42.1 million ($61.8 million).

Den Hartogh said the merger, which is expected to close during the first quarter of 2016, would create a stronger, global organization with an enhanced service portfolio providing significant operational benefits to customers.

The company added that InterBulk’s significant global footprint would enable it to accelerate its international strategy in important growth markets such as China and the US. Pieter den Hartogh, group managing director of Den Hartogh, said scale and global reach were increasingly important success factors.

In particular, Den Hartogh expected to be able to benefit from InterBulk’s relationship with Sinotrans, one of China’s largest logistics companies.

The combined company will have almost 1,600 employees located in offices across 23 countries. It will continue to trade as Den Hartogh, and retain its headquarters in Rotterdam, the Netherlands.

This latest deal follows Den Hartogh’s acquisition of Belgian Sitra-Group’s bulk liquid chemical assets announced on Dec. 1, 2015.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read